AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Business Editors/High-Tech Writers
SAN DIEGO--(BUSINESS WIRE)--June 8, 2004
Cell Bio-Systems, Inc. (Pink Sheets:CBSI), a biotechnology company seeking to manufacture and distribute patented, disposable technologies for cosmetic surgery and other living tissue procedures, announced today that its president and CEO, Marc Pilkington, is currently featured on MacReport.net, a leading financial news and information portal. Visitors to the site and interested investors are encouraged to listen to streamed audio of his presentation or read a full transcript at: http://www.macreport.net/featured/CBSI/company.asp.
Pilkington described his company's business model and strategy of rapid expansion into the plastic and cosmetic surgery marketplace. He also cited the dramatic growth trends in fat injection and liposuction procedures that ultimately led to, and continue to validate, his company's short-term market focus.
Looking ahead, Pilkington affirmed the significant role of gene therapy in the future of medicine. "Cell Bio-Systems is determined to lead the way in research and development of bio instrumentation and procedures which will provide the cornerstone for future drug and genome therapies," he said.
About Cell Bio-Systems
Based in San Diego, California, Cell Bio-Systems is the exclusive licensee of two patented syringe connection products that it plans to adapt as disposable devices for liposuction and other Living Tissue Management(TM) procedures. The company is developing an affordable, disposable product line that will fill this void in the cosmetic surgery ...